Alkermes plc Description
Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia; AMPYRA/ FAMPYRA for the treatment of multiple sclerosis; BYDUREON for the treatment of type II diabetes; VIVITROL for alcohol and opioid dependence; TRICOR, LIPANTHYL, LIPIDIL, and SUPRALIP to lower cholesterol; ZANAFLEX for muscle spasticity; AVINZA for severe pain; EMEND for the treatment of nausea associated with chemotherapy and surgery; and FOCALIN XR and RITALIN LA for attention deficit and hyperactivity disorder. Its products also include MEGACE ES for the treatment of cachexia associated with AIDS; LUVOX CR for obsessive-compulsive disorder; RAPAMUNE for the prevention of renal transplant rejection; NAPRELAN for various mild to moderate pain indications; VERAPAMIL SR, VERELAN, VERELAN PM, VERAPAMIL PM, VERECAPS, UNIVER, and AFE Ditab CR for hypertension; and DILZEM SR, DILZEM XL, DILTELAN, ACALIX CD, DINISOR, TILAZEM CR, and CARDIZEM CD for hypertension and/or angina. In addition, it develops ALKS 9070, which is in phase 3 study for the treatment of schizophrenia; ALKS 37 that is under phase 2b study for the treatment of opioid-induced constipation; ALKS 33, which has completed phase 2 study for modulation of brain opioid receptors; ALKS 5461 that is under phase 2 study for the treatment of depressive disorder, as well as under phase 1b study for the treatment of cocaine dependence; and ZOHYDRO for pain relief. The company serves pharmaceutical wholesalers, specialty pharmacies, and specialty distributors directly through its sales force. It has collaboration with Janssen Pharmaceutica N.V. for the development of RISPERDAL CONSTA. The company was founded in 1987 and is headquartered in Dublin, Ireland.
Classification
Sector:
Healthcare
Industry:
Biotechnology
Keywords:
Biopharmaceutical
Pain
Alcohol
Diabetes
Surgery
Hypertension
Chemotherapy
Opioids
Spas
Lipid
Schizophrenia
Multiple Sclerosis
Cholesterol
Neurochemistry
Organic Chemistry
Depressive Disorder
Morphinans
Nausea
Constipation
Angina
Hyperactivity Disorder
I Diabetes
Obsessive Compulsive Disorder
Treatment Of Schizophrenia
Cachexia
Ii Diabetes
Atypical Antipsychotics
Cocaine
Opioid Receptors
Spasticity
Transplant Rejection
Treatment Of Multiple Sclerosis
Luvox Cr
Opioid Antagonists
Opioid Induced Constipation
Pharmaceutical Wholesalers
Zanaflex